Hunan Er-Kang Pharmaceutical Co. Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 832.432 million compared to CNY 1,202.263 million a year ago. Operating income was CNY 120.623 million compared to CNY 74.687 million a year ago. Net income was CNY 103.286 million compared to CNY 66.152 million a year ago. Basic earnings per share from continuing operations was CNY 0.0501 compared to CNY 0.0321 a year ago.